WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDiagnostics & Research
Best Diagnostic & Research Stocks to Buy Now (2023)
Top diagnostic & research stocks in 2023 ranked by overall Zen Score. See the best diagnostic & research stocks to buy now, according to analyst forecasts for the diagnostics & research industry.

Industry: Diagnostics & Research
OverviewZen ScorePriceValuationFinancialsForecastEarnings & RevenueDividends
OwnershipTechnicals
Ticker
Company
Dividends Score
Market Cap
Dividend Yield
Payout Ratio
Last Dividend
Annual Dividend
Dividend Percentile
Dividend Dropped Count (L10Y)
Ex-dividend Date
Div. Payment Date
ENZ
ENZO BIOCHEM INC
$63.11MN/A0.00%N/AN/AN/AN/A
FONR
FONAR CORP
$130.04MN/A0.00%N/AN/AN/AN/A
QGEN
QIAGEN NV
$9.39BN/A0.00%N/AN/AN/AN/A
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL INC
$10.11BN/A0.00%N/AN/AN/AN/A
IDXX
IDEXX LABORATORIES INC
$38.69BN/A0.00%N/AN/AN/AN/A
RVTY
REVVITY INC
$10.97B0.31%4.80%$0.0700$0.283%02024-01-182024-02-09
STRR
STAR EQUITY HOLDINGS INC
$17.57MN/A0.00%$0.5500N/AN/A0
MEDP
MEDPACE HOLDINGS INC
$8.31BN/A0.00%N/AN/AN/AN/A
ICLR
ICON PLC
$21.95BN/A0.00%N/AN/AN/AN/A
A
AGILENT TECHNOLOGIES INC
$37.39B0.70%23.10%$0.2250$0.9010%12023-12-292024-01-24
EXAS
EXACT SCIENCES CORP
$11.57BN/A0.00%N/AN/AN/AN/A
DGX
QUEST DIAGNOSTICS INC
$15.43B2.03%41.00%$0.7100$2.7937%02024-01-162024-01-31
CSTL
CASTLE BIOSCIENCES INC
$537.94MN/A0.00%N/AN/AN/AN/A
TWST
TWIST BIOSCIENCE CORP
$1.39BN/A0.00%N/AN/AN/AN/A
LH
LABORATORY CORP OF AMERICA HOLDINGS
$18.42B1.33%37.80%$0.7200$2.8823%02023-12-12
OLK
OLINK HOLDING AB (PUBL)
$3.21BN/A0.00%N/AN/AN/AN/A
DHR
DANAHER CORP
$165.01B0.47%13.20%$0.2700$1.066%1
TMO
THERMO FISHER SCIENTIFIC INC
$191.55B0.27%8.80%$0.3500$1.353%02023-12-142024-01-16
DMTK
DERMTECH INC
$55.13MN/A0.00%N/AN/AN/AN/A
DRIO
DARIOHEALTH CORP
$32.93MN/A0.00%N/AN/AN/AN/A
CDNA
CAREDX INC
$525.30MN/A0.00%N/AN/AN/AN/A
MTD
METTLER TOLEDO INTERNATIONAL INC
$23.68BN/A0.00%N/AN/AN/AN/A
WAT
WATERS CORP
$16.59BN/A0.00%N/AN/AN/AN/A
APDN
APPLIED DNA SCIENCES INC
$12.02MN/A0.00%N/AN/AN/AN/A
SERA
SERA PROGNOSTICS INC
$60.79MN/A0.00%N/AN/AN/AN/A
BNR
BURNING ROCK BIOTECH LTD
$84.93MN/A0.00%N/AN/AN/AN/A
RDNT
RADNET INC
$2.26BN/A0.00%N/AN/AN/AN/A
FLGT
FULGENT GENETICS INC
$817.28MN/A0.00%N/AN/AN/AN/A
GH
GUARDANT HEALTH INC
$2.97BN/A0.00%N/AN/AN/AN/A
NTRA
NATERA INC
$6.72BN/A0.00%N/AN/AN/AN/A
LAB
STANDARD BIOTOOLS INC
$204.84MN/A0.00%N/AN/AN/AN/A
NEOG
NEOGEN CORP
$3.67BN/A0.00%N/AN/AN/AN/A
BGLC
BIONEXUS GENE LAB CORP
$16.78MN/A0.00%N/AN/AN/AN/A
NOTV
INOTIV INC
$63.68MN/A0.00%N/AN/AN/AN/A
NEO
NEOGENOMICS INC
$2.32BN/A0.00%N/AN/AN/AN/A
ACRS
ACLARIS THERAPEUTICS INC
$61.98MN/A0.00%N/AN/AN/AN/A
PRPO
PRECIPIO INC
$9.69MN/A0.00%N/AN/AN/AN/A
XWEL
XWELL INC
$9.95MN/A0.00%N/AN/AN/AN/A
PRPH
PROPHASE LABS INC
$91.49MN/A0.00%$0.3000N/AN/A0
GTH
GENETRON HOLDINGS LTD
$112.71MN/A0.00%N/AN/AN/AN/A
PSNL
PERSONALIS INC
$75.02MN/A0.00%N/AN/AN/AN/A
AWH
ASPIRA WOMEN's HEALTH INC
$32.87MN/A0.00%N/AN/AN/AN/A
ME
23ANDME HOLDING CO
$412.51MN/A0.00%N/AN/AN/AN/A
STIM
NEURONETICS INC
$52.66MN/A0.00%N/AN/AN/AN/A
CHEK
CHECK-CAP LTD
$17.02MN/A0.00%N/AN/AN/AN/A
GENE
GENETIC TECHNOLOGIES LTD
$16.85MN/A0.00%N/AN/AN/AN/A
NVTA
INVITAE CORP
$145.54MN/A0.00%N/AN/AN/AN/A
BIAF
BIOAFFINITY TECHNOLOGIES INC
$15.77MN/A0.00%N/AN/AN/AN/A
OPK
OPKO HEALTH INC
$1.13BN/A0.00%N/AN/AN/AN/A
NDRA
ENDRA LIFE SCIENCES INC
$8.39MN/A0.00%N/AN/AN/AN/A
ILMN
ILLUMINA INC
$16.19BN/A0.00%N/AN/AN/AN/A
ISPC
ISPECIMEN INC
$5.08MN/A0.00%N/AN/AN/AN/A
IQV
IQVIA HOLDINGS INC
$39.07BN/A0.00%N/AN/AN/AN/A
MYGN
MYRIAD GENETICS INC
$1.57BN/A0.00%N/AN/AN/AN/A
XGN
EXAGEN INC
$31.36MN/A0.00%N/AN/AN/AN/A
SHC
SOTERA HEALTH CO
$3.86BN/A0.00%N/AN/AN/AN/A
PMD
PSYCHEMEDICS CORP
$14.85M5.47%-30.90%$0.0700$0.1479%1
PRE
PRENETICS GLOBAL LTD
$49.32MN/A0.00%N/AN/AN/AN/A
BDSX
BIODESIX INC
$134.81MN/A0.00%N/AN/AN/AN/A
OCX
ONCOCYTE CORP
$31.39MN/A0.00%N/AN/AN/AN/A
LMDX
LUMIRADX LTD
$54.85MN/A0.00%N/AN/AN/AN/A
VNRX
VOLITIONRX LTD
$59.64MN/A0.00%N/AN/AN/AN/A
CNTG
CENTOGENE NV
$35.10MN/A0.00%N/AN/AN/AN/A
MDXH
MDXHEALTH SA
$8.73MN/AN/AN/AN/AN/AN/A
TTOO
T2 BIOSYSTEMS INC
$14.34MN/A0.00%N/AN/AN/AN/A
TRIB
TRINITY BIOTECH PLC
$18.18MN/AN/A$0.2200N/AN/A0
MYNZ
MAINZ BIOMED NV
$17.82MN/AN/AN/AN/AN/AN/A
1

Diagnostic & Research Stocks FAQ

What are the best diagnostic & research stocks to buy right now in Dec 2023?

According to Zen Score, the 3 best diagnostic & research stocks to buy right now are:

1. Enzo Biochem (NYSE:ENZ)


Enzo Biochem (NYSE:ENZ) is the top diagnostic & research stock with a Zen Score of 51, which is 24 points higher than the diagnostic & research industry average of 27. It passed 16 out of 33 due diligence checks and has strong fundamentals. Enzo Biochem has seen its stock lose -37.19% over the past year, underperforming other diagnostic & research stocks by -20 percentage points.

2. Qiagen Nv (NYSE:QGEN)


Qiagen Nv (NYSE:QGEN) is the second best diagnostic & research stock with a Zen Score of 47, which is 20 points higher than the diagnostic & research industry average of 27. It passed 15 out of 33 due diligence checks and has strong fundamentals. Qiagen Nv has seen its stock lose -16.92% over the past year.

Qiagen Nv has an average 1 year price target of $50.50, an upside of 22.69% from Qiagen Nv's current stock price of $41.16.

Qiagen Nv stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Qiagen Nv, 50% have issued a Strong Buy rating, 25% have issued a Buy, 25% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Fonar (NASDAQ:FONR)


Fonar (NASDAQ:FONR) is the third best diagnostic & research stock with a Zen Score of 47, which is 20 points higher than the diagnostic & research industry average of 27. It passed 14 out of 33 due diligence checks and has strong fundamentals. Fonar has seen its stock return 1.12% over the past year, overperforming other diagnostic & research stocks by 18 percentage points.

What are the diagnostic & research stocks with highest dividends?

Out of 6 diagnostic & research stocks that have issued dividends in the past year, the 3 diagnostic & research stocks with the highest dividend yields are:

1. Quest Diagnostics (NYSE:DGX)


Quest Diagnostics (NYSE:DGX) has an annual dividend yield of 2.03%, which is 1 percentage points higher than the diagnostic & research industry average of 1.51%. Quest Diagnostics's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Quest Diagnostics's dividend has shown consistent growth over the last 10 years.

Quest Diagnostics's dividend payout ratio of 41% indicates that its dividend yield is sustainable for the long-term.

2. Laboratory Of America Holdings (NYSE:LH)


Laboratory Of America Holdings (NYSE:LH) has an annual dividend yield of 1.33%, which is the same as the diagnostic & research industry average of 1.51%. Laboratory Of America Holdings's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Laboratory Of America Holdings's dividend has not shown consistent growth over the last 10 years.

Laboratory Of America Holdings's dividend payout ratio of 37.8% indicates that its dividend yield is sustainable for the long-term.

3. Agilent Technologies (NYSE:A)


Agilent Technologies (NYSE:A) has an annual dividend yield of 0.7%, which is -1 percentage points lower than the diagnostic & research industry average of 1.51%. Agilent Technologies's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Agilent Technologies's dividend has shown consistent growth over the last 10 years.

Agilent Technologies's dividend payout ratio of 23.1% indicates that its dividend yield is sustainable for the long-term.

Why are diagnostic & research stocks up?

Diagnostic & research stocks were up 0.12% in the last day, and down -0.14% over the last week.

We couldn't find a catalyst for why diagnostic & research stocks are up.

What are the most undervalued diagnostic & research stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued diagnostic & research stocks right now are:

1. Enzo Biochem (NYSE:ENZ)


Enzo Biochem (NYSE:ENZ) is the most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Enzo Biochem has a valuation score of 71, which is 50 points higher than the diagnostic & research industry average of 21. It passed 5 out of 7 valuation due diligence checks.

Enzo Biochem's stock has dropped -37.19% in the past year. It has underperformed other stocks in the diagnostic & research industry by -20 percentage points.

2. Star Equity Holdings (NASDAQ:STRR)


Star Equity Holdings (NASDAQ:STRR) is the second most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Star Equity Holdings has a valuation score of 71, which is 50 points higher than the diagnostic & research industry average of 21. It passed 5 out of 7 valuation due diligence checks.

Star Equity Holdings's stock has gained 14.43% in the past year. It has overperformed other stocks in the diagnostic & research industry by 31 percentage points.

3. Fonar (NASDAQ:FONR)


Fonar (NASDAQ:FONR) is the third most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Fonar has a valuation score of 71, which is 50 points higher than the diagnostic & research industry average of 21. It passed 5 out of 7 valuation due diligence checks.

Fonar's stock has gained 1.12% in the past year. It has overperformed other stocks in the diagnostic & research industry by 18 percentage points.

Are diagnostic & research stocks a good buy now?

54.9% of diagnostic & research stocks rated by analysts are a strong buy right now. On average, analysts expect diagnostic & research stocks to rise by 16.24% over the next year.

What is the average p/e ratio of the diagnostics & research industry?

The average P/E ratio of the diagnostics & research industry is 30.73x.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.